Physician profile
Peter Hanna
NPI 1588906929
$23,977.67
in general payments reported to CMS, 2019-2025
10 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $19K · 2023: $2,833 · 2024: $1,081 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,881 · Grant: $1,500 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,880.50 |
| Grant | $1,500.00 |
| Education | $304.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,537.90 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $7,841.24 | 2022-2025 | General - Therapies, Emblem Mri S-Icd |
| Abbott Laboratories | $2,174.76 | 2022-2025 | Ensite, Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Biotronik INC. | $884.56 | 2021-2023 | |
| Bioventus LLC | $186.49 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Biosense Webster, INC. | $145.92 | 2025 | Carto 3 |
| Philips North America LLC | $102.50 | 2022 | |
| Baylis Medical Company INC | $56.39 | 2021 | |
| Lilly USA, LLC | $34.32 | 2024 | Mounjaro |
| Cook Medical LLC | $13.59 | 2023 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.